SCHEMBL22236740

SCHEMBL22236740

COC(=O)CCC[C@@H]1CC(=O)[C@@]2(C)CCC3c4ccc(Cl)cc4CCC3C12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 6/20 0.45
▸ STS P08842 2/20 0.45
▸ LMNA P02545 4/20 0.44
▸ MAPT P10636 4/20 0.44
▸ ESR1 P03372 2/20 0.44
▸ PGR P06401 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ AR P10275 2/20 0.44
▸ AKR1B10 O60218 1/20 0.44
▸ SHBG P04278 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ SERPINA6 P08185 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44
▸ AKR1B1 P15121 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ OPRM1 P35372 1/20 0.44
▸ SNCA P37840 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ BLM P54132 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22088746 0.95 STS (0.48) HSD17B1STSLMNAMAPTESR1
SCHEMBL22088747 0.95 STS (0.48) HSD17B1STSLMNAMAPTESR1
SCHEMBL22089279 0.95 STS (0.48) HSD17B1STSLMNAMAPTESR1
SCHEMBL22236698 0.95 STS (0.48) HSD17B1STSLMNAMAPTESR1
SCHEMBL22524226 0.93 HSD17B1 (0.53) HSD17B1STSLMNAMAPTESR1
SCHEMBL22236741 0.93 HSD17B1 (0.53) HSD17B1STSLMNAMAPTESR1
SCHEMBL22236742 0.90 HRH3 (0.46) HSD17B1STSLMNAMAPTESR1
SCHEMBL22524224 0.90 STS (0.53) HSD17B1STSLMNAMAPTESR1
SCHEMBL18661043 0.89 LMNA (0.56) HSD17B1LMNAMAPTESR1HSD17B10
SCHEMBL22236702 0.87 STS (0.56) HSD17B1STSLMNAMAPTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717761-B2 Therapeutically active steroidal derivatives FORENDO PHARMA LTD (FI) 2020-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717761-B2 Therapeutically active steroidal derivatives HSD17B11, NR5A1, CYP17A1 HSD17B1 4/4885STS 36/4885LMNA 2414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback